Statins and Cardiovascular Health: Controversy, Consensus, and Clinical Judgment

J Cardiovasc Nurs. 2017 Mar/Apr;32(2):90-92. doi: 10.1097/JCN.0000000000000394.

Authors

Laura L Hayman¹, Cheryl Dennison Himmelfarb

Affiliation

¹ Laura L. Hayman, PhD, RN, FAAN Associate Vice Provost for Research and Graduate Studies and Professor of Nursing, University of Massachusetts Boston. Cheryl Dennison Himmelfarb, PhD, RN, ANP, FAAN Director, Office for Science and Innovation, and Deputy Director, Institute for Clinical Translational Research, Johns Hopkins School of Nursing, Baltimore, Maryland.

PMID: 28178028
DOI: 10.1097/JCN.0000000000000394

No abstract available

MeSH terms

Attitude of Health Personnel
Cardiovascular Diseases / prevention & control*
Cardiovascular Nursing*
Consensus*
Health Status
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Primary Prevention / methods*

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors